Arbutus Biopharma Corporation
ABUS
|
News
|
$2.73
-1.8%
-1.83%
1M
|
Health Technology
(0.0% 1d) (7.8% 1m) (-7.1% 1y) (0.0% 2d) (-5.8% 3d) (-7.4% 7d) (NaN% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 490,013,703
http://www.arbutusbio.com
Sec Filling | Patents | 80 employees
(US) Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.
hepatitis injection
add to watch list Paper trade email alert is off
Press-releases
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -5.82%
H: 0.0%
C: 0.0%
first report update financial results
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
MRNA S | $102.0 -1.39% -1.4% 1.4M
|
Health Technology
|
| O: 1.46%
H: 3.2%
C: -0.41%
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 16.73%
H: 6.14%
C: 2.39%
patent construction biopharma ongoing
Barinthus Bio Reports Full Year 2023 Financial Results and Update on Corporate Developments
Published: 2024-03-20 (Crawled : 12:00) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -1.58%
H: 3.05%
C: 2.41%
year update financial results
Lipid-Nanoparticle Based Genomic Medicines Market worth $32.5 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2024-03-18 (Crawled : 14:00) - prnewswire.com
CVAC | News | $2.44 -5.06% -5.33% 670K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.73%
BNTX | $86.17 -0.27% -0.24% 520K
|
Health Technology
|
| O: 0.48%
H: 1.18%
C: 0.08%
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.38%
H: 0.38%
C: -3.42%
report genomic market
Arbutus to Participate in Two Upcoming Investor Conferences
Published: 2024-03-08 (Crawled : 12:30) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus to Participate in Two Upcoming Investor Conferences - March 8, 2024
Published: 2024-03-08 (Crawled : 14:30) - biospace.com/
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: 0.0%
Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update
Published: 2024-02-29 (Crawled : 12:30) - globenewswire.com
ROIV | $10.36 -0.77% -0.68% 3.4M
|
Manufacturing
|
| O: 1.2%
H: 0.34%
C: -3.46%
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: -1.37%
H: 0.0%
C: -2.44%
year update financial results
Arbutus to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 0.85%
H: 0.0%
C: -1.36%
report year update financial results
Arbutus Announces 2024 Corporate Objectives and Provides Financial Update
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 3.32%
H: 3.21%
C: -1.61%
update financial
Barinthus Bio Presents Interim Data from Phase 2b HBV003 Trial and Phase 2a AB-729-202 Trial in Collaboration with Arbutus Biopharma in Chronic HBV Patients at AASLD
Published: 2023-11-09 (Crawled : 21:00) - globenewswire.com
ABUS | News | $2.73 -1.8% -1.83% 1M
|
Health Technology
|
| O: 1.67%
H: 0.0%
C: -3.28%
hbv003 biopharma collaboration trial
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 59% | 41% |
Top 10 Gainers
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
TPET | $0.3279 -3.56% 28.48% 33M
|
n/a
GDHG | $0.263 21.76% 25.34% 1.3M
|
HOLO | $2.95 31.7% 22.49% 37M
|
UMAC | $1.55 0.65% 16.13% 3K
|
MTNB | $0.19 -1.04% 14.58% 950K
|
Health Technology
VLD 4 | $0.2638 -3.65% 13.27% 2.6M
|
Manufacturing
ALLR | $1.54 2.67% 11.76% 740K
|
n/a
MGLD 4 | $1.13 5.61% 10.62% 200
|
Manufacturing
NURO | $3.65 2.24% 10.3% 3.9K
|
Health Technology
Last 48 Hours Insiders Buying
FNLC P 1275 | $22.16 -0.36% 0.34% 16K
|
Finance
|
12:30
ADMQ | $0.0532 -4.14% -40.18% 480K
|
|
10:30
AXR P 2400 | $22.17 2.69% 0.0% 5.5K
|
Finance
|
21:00
QCRH P 118 | $55.41 1.34% 1.31% 54K
|
Finance
|
18:01
VUZI P 7500 | $1.26 3.28% 3.17% 930K
|
Electronic Technology
|
18:00
RMCF | $3.5501 0.57% 2.22% 18K
|
Consumer Non-Durables
|
20:10